Fibrinogen Human Not Yet Recruiting Phase 4 Trials for Total Blood Loss Prevention

IndicationsStatusPurposePhase
Not Yet RecruitingPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT03310060Reducing Blood Loss Using Tisseel in TKA